50 employees
Novellus is a biotechnology company working to develop engineered cellular medicines.
2015
$57M
from 3 investors over 3 rounds
Novellus, Inc. raised $57M on September 23, 2020
Investors: Wellington Management, Pontifax Venture Capital and OrbiMed Advisors